Previous studies, monitoring walking speed and jumping height, have suggested that
HRT reduces the impacts of age - related decline in muscle mass and strength.
Not exact matches
The U.S. study testing the long - term benefits and risks of hormone replacement therapy (
HRT) was halted after an interim analysis found that the drugs — a combination of estrogen and progestin — increased the risk of breast cancer, stroke, and heart disease, and that those risks outweighed
reduced risks of colorectal cancer and bone fractures (ScienceNOW, 9 July).
It is thought that using
HRT, at least in part,
reduces modifications of muscle contractile proteins that are linked to ageing.»
Although it was believed estrogen conferred cardiac protection and
reduced the incidence of myocardial ischemic events and cerebrovascular accidents, the more recent literature indicates that this is not true and that
HRT users have a higher risk of cardiac and cerebral events.»
Talk about confusing: First, hormone replacement therapy (
HRT) was hailed as a miracle drug that might not only ease menopause symptoms, such as hot flashes and insomnia, but also
reduce the risk of osteoporosis and heart disease.
Hormone replacement therapy (
HRT) is one of the best ways to at least postpone the adverse effects of
reduced oestrogen and progesterone.
The discussion will involve what the patient feels
HRT can do for them, what goals they have and what symptoms they are trying to
reduce or eliminate.
That vindicates Dr. Lee's position that conventional
HRT can often
reduce the body's ability to inhibit breast tumor growth.
The buy back
reduces HRT's total liquidating value from $ 12.7 M to $ 12.0 M, but increases the per share liquidating value from $ 4.68 to $ 4.97.